2007
DOI: 10.1002/jmri.21217
|View full text |Cite
|
Sign up to set email alerts
|

Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation

Abstract: Purpose:To determine whether diffusion abnormalities can be observed in nonsymptomatic family members with a known causative Cu/Zn superoxide dismutase mutation (asymptomatic familial amyotrophic lateral sclerosis; AFALS ϩSOD1 ) in a family with autosomal dominant familial amyotrophic lateral sclerosis (ALS) using diffusion tensor imaging (DTI). Materials and Methods:A total of eight AFALS ϩSOD1 subjects (aged 17-43 years) were age-matched with 13 healthy controls (aged 19 -45 years) without SOD1 mutations. DT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
29
1

Year Published

2009
2009
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(31 citation statements)
references
References 35 publications
1
29
1
Order By: Relevance
“…38 The lack of knowledge of the at-risk population and uncertainty over where the clinical horizon lies in relation to the start of the pathologic cascade currently hampers MRI study of the very earliest changes beyond rare familial cases. 39 Early peridiagnostic as well as longitudinal studies will be important for validation of the present findings.…”
Section: Figure 2 Regional Fractional Anisotropy (Fa) Reductions and mentioning
confidence: 58%
“…38 The lack of knowledge of the at-risk population and uncertainty over where the clinical horizon lies in relation to the start of the pathologic cascade currently hampers MRI study of the very earliest changes beyond rare familial cases. 39 Early peridiagnostic as well as longitudinal studies will be important for validation of the present findings.…”
Section: Figure 2 Regional Fractional Anisotropy (Fa) Reductions and mentioning
confidence: 58%
“…32 It is similarly believed that the neurodegenerative process in ALS may begin prior to the onset of symptoms, but there are relatively little human data to support this hypothesis. [2][3][4] An important reason for the paucity of human data is the practical difficulty of studying people at risk for ALS prior to the onset of symptoms. Pre-fALS is a prospective observational study of asymptomatic individuals from familial ALS pedigrees who harbor a mutation in an ALS susceptibility gene and are at high risk for developing ALS.…”
Section: Resultsmentioning
confidence: 99%
“…There are inconsistent reports of structural and functional MRI abnormalities prior to symptom onset in those at high genetic risk of ALS [Carew et al, 2011; Menke et al, 2016; Ng et al, 2008; Vucic et al, 2008; Walhout et al, 2015]. Evidence of cortical hyperexcitability in asymptomatic carriers of genetic mutations who are “at risk” of ALS is restricted to a very limited finding of reduced ligand [ 11 C]‐flumazenil binding in two individuals with the D90A SOD1 mutation [Turner et al, 2005a], and three SOD1 mutation carriers who demonstrated reduced or absent intra‐cortical inhibition within three months of symptom onset [Vucic et al, 2008].…”
Section: Discussionmentioning
confidence: 99%